Jeffrey Yaste, MD
Orthopaedic Surgery · Asheboro, NCNPI 1811036841
Payments from drug & device makers
What this record shows
This record is dominated by education: $3,192 of the $4,325 with a category attached, or 73.8%. Southtech Orthopedics accounts for 73.8% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2021 at $2,707 and has fallen 93.7% since, to $172 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in NC, where the typical reported total is $4,547.
Across 53 payments — averaging $81.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Southtech Orthopedics$3K
- Endo Pharmaceuticals Inc.$127
- Arthrex$122
- Heron Therapeutics, Inc.$114
- Boston Scientific$113
- Stryker$100
- plus $556 from 14 others
What the payments were for
- Food & beverage$1,13326%
- Education$3,19274%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Southtech Orthopedics | 3 | $3,192 |
| Endo Pharmaceuticals Inc. | 7 | $127 |
| Arthrex | 1 | $122 |
| Heron Therapeutics, Inc. | 3 | $114 |
| Boston Scientific | 6 | $113 |
| Stryker | 4 | $100 |
| Johnson & Johnson(2 entities) | 6 | $87 |
| Piedmont Plus Innovation | 2 | $81 |
| Smith+Nephew | 3 | $80 |
| Amgen | 4 | $59 |
| Medtronic(2 entities) | 4 | $59 |
| Bioventus LLC | 2 | $50 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Moximed, Inc | 1 | $21 |
| ERMI LLC | 1 | $20 |
| Vertex | 1 | $19 |
| Abbott | 1 | $17 |
| KCI USA, Inc. | 1 | $15 |
| Heraeus Medical, LLC. | 1 | $13 |
| Kerecis Limited | 1 | $13 |
How this compares
$4,325 in reported general payments places this provider in the 45th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 17 | $185 |
| Methylprednisolone | 26 | $134 |
| Mupirocin | 14 | $88 |
| Oxycodone Hcl | 15 | $52 |
| Amoxicillin | 23 | $15 |
| Meloxicam | 13 | $15 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Asheboro
- Thomas FehringCharlotte$18.3M
- Walter BeaverCharlotte$7.4M
- Robert AndersonCharlotte$6.6M
- William JiranekDurham$6.4M
- John MasonCharlotte$5.7M
- Thomas VailDurham$5.7M
- William DavisCharlotte$5.2M
- John EllingtonCharlotte$4.9M
- Mark EasleyDurham$4M
- Carroll JonesCharlotte$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.